Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 13,000 shares, a growth of 106.3% from the March 15th total of 6,300 shares. Based on an average daily volume of 258,600 shares, the short-interest ratio is […]